Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2022 | YoY |
|---|---|---|
| Revenue | 80.82M | 32.59% |
| Gross profit | 3.35M | 78.37% |
| Net profit | -48.79M | 8,368.40% |
| EBITDA | -40.79M | 1,909.12% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €28.52M |
Number of shares | 6.95M |
52-week high/low | €6.74 - €1.90 |
| Dividends | No |
Beta | 0.22 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.00 |
P/S ratio | 0.13 |
Company profile
Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Biotech Group Limited and changed its name to Happiness Development Group Limited in November 2021. Happiness Development Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
| Name | HAPPINESS BIOT.GRP -,0005 |
| CEO | Xuezhu Wang |
| Headquarters | Nanping,
China |
| Website | |
| Sector | Consumer Staples |
| Industry | Personal Care Products |
| IPO | 10/25/2019 |
| Employees | 218 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | HAPP |